This inventor holds 1 USPTO granted patent. Top assignee: Hyundai Pharm Co., Ltd.. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Sehoan Kim: Innovator in Pharmaceutical Compounds
Introduction
Sehoan Kim is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific enzymes in the human body. His work is characterized by a focus on enhancing the efficacy and solubility of pharmaceutical compositions.
Latest Patents
Sehoan Kim holds 1 patent for a compound aimed at inhibiting human 11-β-hydroxy steroid dehydrogenase type 1 (11β-HSD1). The patent describes a novel compound or a pharmaceutically acceptable salt thereof, along with a pharmaceutical composition that includes this compound. The disclosed compound is noted for its excellent activity and solubility, making it more efficient for formulation and transfer in medical applications.
Career Highlights
Sehoan Kim is currently associated with Hyundai Pharm Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing treatments that target metabolic disorders and other health issues related to steroid metabolism.
Collaborations
Sehoan Kim has collaborated with notable colleagues, including Doohyeok Pyeon and Inhee Lee. These partnerships have contributed to the successful development of his patented compounds and have fostered a collaborative environment for innovation.
Conclusion
Sehoan Kim's contributions to pharmaceutical innovation highlight the importance of targeted therapies in modern medicine. His work not only advances scientific knowledge but also has the potential to improve patient outcomes significantly.